Bangladesh. The manufacture, distribution, sale and use of all dosage forms of nimesulide paediatric preparations were recently officially banned in Bangladesh. The banning of adult dosage forms of nimesulide preparations is now under active consideration of the Directorate of Drugs Administration of Bangladesh. A nation wide survey of reports of adverse effects with nimesulide is being conducted before taking a final decision with the adult usage formulations. Importation of nimesulide raw material has already been discontinued in order to discourage further manufacture of nimesulide preparations in the country.

Reference:
Communication to WHO, Geneva, from Director, Directorate of Drugs Administration, Ministry of Health and Family Welfare, Bangladesh, 11 Jun 2003.